Search
for
Sort by
Research 31–60 of 1000+
- Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature
- Inhibidores de JAK: usos en dermatología. Parte 1: generalidades, aplicaciones en vitíligo y en alopecia areata
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Under Development JAK Inhibitors for Dermatologic Diseases
- Interleukin 6 and STAT3 regulate p63 isoform expression in keratinocytes during regeneration
- JAK Inhibitors: A New Weapon in the Skin Care Providers' Arsenal.
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- JAK Inhibitors in the Treatment of Alopecia Areata: Efficacy, Safety, and Long-term Outcomes
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- APECED: JAK Inhibition in an Adult Case with Long-Term Follow-up
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- 681 Inhibition of STAT3, using Oenocarpus bataua vegetable oil, on in vitro model
- JAK Family Expression and Therapeutic Implications in Primary Cicatricial Alopecias
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Delphi Consensus Statement on Treatment of Severe Alopecia Areata in US Adults
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- 026 Targeting pathogenic MICA-NKG2D interactions by statins: A novel adjunct treatment strategy for alopecia areata management?
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Alopecia areata: Time for position statement to include new systemic therapeutic advances
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Overview of alopecia areata for managed care and payer stakeholders in the United States